$4.23
-0.28-6.62%
At close: Sep 3, 9:30 AM EDT
$3.95
-0.28-6.62%
After Hours: Sep 3, 9:30 AM EDT
15 minutes delayed
Comments
Loading...
Cosciens Biopharma (CSCI) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCosciens Biopharma (NASDAQ:CSCI) Stock Quotes, Forecast and News Summary
Cosciens Biopharma Stock (NASDAQ: CSCI) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 10.65K |
| Day Range | - - - |
| 52 Wk Range | 3.49 - 6.77 |
| Market Cap | $12.31M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 42 |
| Short Interest | - |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified p...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cosciens Biopharma (CSCI) stock?
You can purchase shares of Cosciens Biopharma (NASDAQ:CSCI) through any online brokerage.
Who are Cosciens Biopharma (CSCI) competitors?
There are no as such competitors for Cosciens Biopharma.
What is the forecast, or price target, for Cosciens Biopharma (CSCI) stock?
There is no analysis for Cosciens Biopharma to provide a consensus price target.
What is the current price for Cosciens Biopharma (CSCI)?
The stock price for Cosciens Biopharma (NASDAQ: CSCI) is $3.95 last updated September 3, 2024 at 9:30 AM EDT.
Does Cosciens Biopharma (CSCI) pay a dividend?
There are no upcoming dividends for Cosciens Biopharma.
When is Cosciens Biopharma (NASDAQ:CSCI) reporting earnings?
Cosciens Biopharma’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Cosciens Biopharma (CSCI) going to split?
There is no upcoming split for Cosciens Biopharma.
What sector and industry does Cosciens Biopharma (CSCI) operate in?
Cosciens Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.